Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002331
Status:
COMPLETED
Last Update Posted:
2015-01-16
First Post:
1999-11-02
Brief Title:
The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
A Randomized Open-Label Study of the Tolerability and Efficacy of Clarithromycin and Ethambutol in Combination With or Without Clofazimine for the Treatment of Disseminated MAC dMAC in Patients With AIDS
Status:
COMPLETED
Status Verified Date:
2009-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
PRIMARY To assess the tolerability of the combination regimen of clarithromycin plus ethambutol with or without clofazimine in patients with disseminated Mycobacterium avium Complex dMAC
SECONDARY To determine the proportion of patients achieving a sterile blood culture along with the time required to achieve it To determine the duration of bacteriological response defined as length of time that blood cultures remain sterile
SECONDARY To determine the proportion of patients achieving a sterile blood culture along with the time required to achieve it To determine the duration of bacteriological response defined as length of time that blood cultures remain sterile
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| M93-069 | None | None | None |